Phillip Schwartz, Ph.D.President of R&D and EVP at Entera Bio Ltd.
Phillip Schwartz , Ph.D., is the Founder and President of Entera Bio. Dr. Schwartz served as the CEO from 2010 till 2019 and is a member of the Board of Directors since 2010. Dr. Schwartz took Entera public on the NASDAQ in 2017 and executed a $270 million collaboration with Amgen in 2018. Prior to Entera Bio Dr. Schwartz held multiple positions at Serono and Endo Pharmaceuticals and has also served as a consultant to more than 20 large biotech and pharmaceutical companies and several venture capital firms. Dr. Schwartz received his Ph.D. in neurobiology/developmental oncology from Harvard Medical School and worked for 2+ years with Nobel Laureate Prof. Torsten Wiesel at the Rockefeller University.